A citation-based method for searching scientific literature

Christina Neuner Boyle, Thomas Alexander Lutz, Christelle Le Foll. Mol Metab 2018
Times Cited: 44







List of co-cited articles
820 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Amylin: Pharmacology, Physiology, and Clinical Potential.
Debbie L Hay, Steve Chen, Thomas A Lutz, David G Parkes, Jonathan D Roth. Pharmacol Rev 2015
178
36

Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies.
Jonathan D Roth, Barbara L Roland, Rebecca L Cole, James L Trevaskis, Christian Weyer, Joy E Koda, Christen M Anderson, David G Parkes, Alain D Baron. Proc Natl Acad Sci U S A 2008
308
22

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.
Xavier Pi-Sunyer, Arne Astrup, Ken Fujioka, Frank Greenway, Alfredo Halpern, Michel Krempf, David C W Lau, Carel W le Roux, Rafael Violante Ortiz, Christine Bjørn Jensen,[...]. N Engl J Med 2015
786
22

Amylin modulates the mesolimbic dopamine system to control energy balance.
Elizabeth G Mietlicki-Baase, David J Reiner, Jackson J Cone, Diana R Olivos, Lauren E McGrath, Derek J Zimmer, Mitchell F Roitman, Matthew R Hayes. Neuropsychopharmacology 2015
62
22

Amylin receptor signaling in the ventral tegmental area is physiologically relevant for the control of food intake.
Elizabeth G Mietlicki-Baase, Laura E Rupprecht, Diana R Olivos, Derek J Zimmer, Mark D Alter, R Christopher Pierce, Heath D Schmidt, Matthew R Hayes. Neuropsychopharmacology 2013
59
22

Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product.
G Christopoulos, K J Perry, M Morfis, N Tilakaratne, Y Gao, N J Fraser, M J Main, S M Foord, P M Sexton. Mol Pharmacol 1999
378
22

Enhanced weight loss with pramlintide/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy.
Eric Ravussin, Steven R Smith, Julie A Mitchell, Reshma Shringarpure, Kevin Shan, Holly Maier, Joy E Koda, Christian Weyer. Obesity (Silver Spring) 2009
212
20

Hypothalamic Amylin Acts in Concert with Leptin to Regulate Food Intake.
Zhiying Li, Leah Kelly, Myriam Heiman, Paul Greengard, Jeffrey Michael Friedman. Cell Metab 2015
60
20

In vitro autoradiographic localization of amylin binding sites in rat brain.
P M Sexton, G Paxinos, M A Kenney, P J Wookey, K Beaumont. Neuroscience 1994
215
20

Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial.
Juan Pablo Frias, Michael A Nauck, Joanna Van, Mark E Kutner, Xuewei Cui, Charles Benson, Shweta Urva, Ruth E Gimeno, Zvonko Milicevic, Deborah Robins,[...]. Lancet 2018
293
20

Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight.
C M Mack, C J Soares, J K Wilson, J R Athanacio, V F Turek, J L Trevaskis, J D Roth, P A Smith, B Gedulin, C M Jodka,[...]. Int J Obes (Lond) 2010
79
20

Amylin receptor activation in the ventral tegmental area reduces motivated ingestive behavior.
Elizabeth G Mietlicki-Baase, Lauren E McGrath, Kieran Koch-Laskowski, Joanna Krawczyk, David J Reiner, Tram Pham, Chan Tran N Nguyen, Christopher A Turner, Diana R Olivos, Mathieu E Wimmer,[...]. Neuropharmacology 2017
29
27

Amylin receptor components and the leptin receptor are co-expressed in single rat area postrema neurons.
Claudia G Liberini, Christina N Boyle, Carlo Cifani, Marco Venniro, Bruce T Hope, Thomas A Lutz. Eur J Neurosci 2016
43
18


Amylin/Calcitonin Receptor-Mediated Signaling in POMC Neurons Influences Energy Balance and Locomotor Activity in Chow-Fed Male Mice.
Bernd Coester, Christina Koester-Hegmann, Thomas A Lutz, Christelle Le Foll. Diabetes 2020
15
53


Once-Weekly Semaglutide in Adults with Overweight or Obesity.
John P H Wilding, Rachel L Batterham, Salvatore Calanna, Melanie Davies, Luc F Van Gaal, Ildiko Lingvay, Barbara M McGowan, Julio Rosenstock, Marie T D Tran, Thomas A Wadden,[...]. N Engl J Med 2021
267
18

Mechanisms of amylin/leptin synergy in rodent models.
Victoria F Turek, James L Trevaskis, Barry E Levin, Ambrose A Dunn-Meynell, Boman Irani, Guibao Gu, Carrie Wittmer, Peter S Griffin, Calvin Vu, David G Parkes,[...]. Endocrinology 2010
101
15

Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans.
E Hartter, T Svoboda, B Ludvik, M Schuller, B Lell, E Kuenburg, M Brunnbauer, W Woloszczuk, R Prager. Diabetologia 1991
186
15

RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor.
L M McLatchie, N J Fraser, M J Main, A Wise, J Brown, N Thompson, R Solari, M G Lee, S M Foord. Nature 1998
15


Infusion of the amylin antagonist AC 187 into the area postrema increases food intake in rats.
Andrea Mollet, Simone Gilg, Thomas Riediger, Thomas A Lutz. Physiol Behav 2004
89
15

Calcitonin Receptor Neurons in the Mouse Nucleus Tractus Solitarius Control Energy Balance via the Non-aversive Suppression of Feeding.
Wenwen Cheng, Ian Gonzalez, Warren Pan, Anthony H Tsang, Jessica Adams, Ermelinda Ndoka, Desiree Gordian, Basma Khoury, Karen Roelofs, Simon S Evers,[...]. Cell Metab 2020
32
21

Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25.
Debbie L Hay, Michael L Garelja, David R Poyner, Christopher S Walker. Br J Pharmacol 2018
166
15

Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial.
Thomas A Wadden, Timothy S Bailey, Liana K Billings, Melanie Davies, Juan P Frias, Anna Koroleva, Ildiko Lingvay, Patrick M O'Neil, Domenica M Rubino, Dorthe Skovgaard,[...]. JAMA 2021
83
15

MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study.
Philip Ambery, Victoria E Parker, Michael Stumvoll, Maximilian G Posch, Tim Heise, Leona Plum-Moerschel, Lan-Feng Tsai, Darren Robertson, Meena Jain, Marcella Petrone,[...]. Lancet 2018
132
13

Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity.
John Blundell, Graham Finlayson, Mads Axelsen, Anne Flint, Catherine Gibbons, Trine Kvist, Julie B Hjerpsted. Diabetes Obes Metab 2017
119
13

GLP-1 and weight loss: unraveling the diverse neural circuitry.
Scott E Kanoski, Matthew R Hayes, Karolina P Skibicka. Am J Physiol Regul Integr Comp Physiol 2016
110
13

The physiology of glucagon-like peptide 1.
Jens Juul Holst. Physiol Rev 2007
13

Future Pharmacotherapy for Obesity: New Anti-obesity Drugs on the Horizon.
Gitanjali Srivastava, Caroline Apovian. Curr Obes Rep 2018
95
13

Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial.
Patrick M O'Neil, Andreas L Birkenfeld, Barbara McGowan, Ofri Mosenzon, Sue D Pedersen, Sean Wharton, Charlotte Giwercman Carson, Cecilie Heerdegen Jepsen, Maria Kabisch, John P H Wilding. Lancet 2018
214
13

The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss.
Anna Secher, Jacob Jelsing, Arian F Baquero, Jacob Hecksher-Sørensen, Michael A Cowley, Louise S Dalbøge, Gitte Hansen, Kevin L Grove, Charles Pyke, Kirsten Raun,[...]. J Clin Invest 2014
408
13


Ghrelin.
T D Müller, R Nogueiras, M L Andermann, Z B Andrews, S D Anker, J Argente, R L Batterham, S C Benoit, C Y Bowers, F Broglio,[...]. Mol Metab 2015
535
13


Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial.
Melanie Davies, Louise Færch, Ole K Jeppesen, Arash Pakseresht, Sue D Pedersen, Leigh Perreault, Julio Rosenstock, Iichiro Shimomura, Adie Viljoen, Thomas A Wadden,[...]. Lancet 2021
82
13


Inhibition of food intake in obese subjects by peptide YY3-36.
Rachel L Batterham, Mark A Cohen, Sandra M Ellis, Carel W Le Roux, Dominic J Withers, Gary S Frost, Mohammad A Ghatei, Stephen R Bloom. N Engl J Med 2003
11

Ghrelin is a growth-hormone-releasing acylated peptide from stomach.
M Kojima, H Hosoda, Y Date, M Nakazato, H Matsuo, K Kangawa. Nature 1999
11

Gut hormone PYY(3-36) physiologically inhibits food intake.
Rachel L Batterham, Michael A Cowley, Caroline J Small, Herbert Herzog, Mark A Cohen, Catherine L Dakin, Alison M Wren, Audrey E Brynes, Malcolm J Low, Mohammad A Ghatei,[...]. Nature 2002
11

Ghrelin induces adiposity in rodents.
M Tschöp, D L Smiley, M L Heiman. Nature 2000
11


Amylin Acts in the Lateral Dorsal Tegmental Nucleus to Regulate Energy Balance Through Gamma-Aminobutyric Acid Signaling.
David J Reiner, Elizabeth G Mietlicki-Baase, Diana R Olivos, Lauren E McGrath, Derek J Zimmer, Kieran Koch-Laskowski, Joanna Krawczyk, Christopher A Turner, Emily E Noble, Joel D Hahn,[...]. Biol Psychiatry 2017
28
17

The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors.
Suzanne L Dickson, Rozita H Shirazi, Caroline Hansson, Filip Bergquist, Hans Nissbrandt, Karolina P Skibicka. J Neurosci 2012
233
11

Ghrelin directly targets the ventral tegmental area to increase food motivation.
K P Skibicka, C Hansson, M Alvarez-Crespo, P A Friberg, S L Dickson. Neuroscience 2011
230
11


Pramlintide treatment reduces 24-h caloric intake and meal sizes and improves control of eating in obese subjects: a 6-wk translational research study.
Steven R Smith, John E Blundell, Colleen Burns, Cinzia Ellero, Brock E Schroeder, Nicole C Kesty, Kim S Chen, Amy E Halseth, Cameron W Lush, Christian Weyer. Am J Physiol Endocrinol Metab 2007
87
11

Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Frank L Greenway, Ken Fujioka, Raymond A Plodkowski, Sunder Mudaliar, Maria Guttadauria, Janelle Erickson, Dennis D Kim, Eduardo Dunayevich. Lancet 2010
460
11

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
11



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.